Heraf var hovedparten (42%) i behandling med cerivastatin, og det var mere sandsynligt, at de samtidig var i behandling med gemfibrozil, end dem, der blev indlagt med myopati og blev behandlet med andre statiner.
Of the myopathy cases, 6.2% were hospitalised: of those diagnosed as inpatients, the largest proportion (42%) were taking cerivastatin and more likely to have concurrent gemfibrozil than those with hospitalised myopathy and other statins.